Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer’s disease
Authors:
Open Access
- 12 October 2023
- journal article
- research article
- Published by Springer Nature in Alzheimer's Research & Therapy
- Vol. 15 (1) , 1-15
Abstract
Background: Compared to standard neuro-diagnostic techniques, retinal biomarkers provide a probable low-cost and non-invasive alternative for early Alzheimer’s disease (AD) risk screening. We have previously quantified the periarteriole and perivenule capillary free zones (mid-peripheral CFZs) in cognitively unimpaired (CU) young and older adults as novel metrics of retinal tissue oxygenation. There is a breakdown of the inner retinal blood barrier, pericyte loss, and capillary non-perfusion or dropout in AD leading to potential enlargement of the mid-peripheral CFZs. We hypothesized the mid-peripheral CFZs will be enlarged in CU older adults at high risk for AD compared to low-risk individuals. Methods: 20 × 20° optical coherence tomography angiography images consisting of 512 b-scans, 512 A-scans per b-scan, 12-µm spacing between b-scans, and 5 frames averaged per each b-scan location of the central fovea and of paired major arterioles and venules with their surrounding capillaries inferior to the fovea of 57 eyes of 37 CU low-risk (mean age: 66 years) and 50 eyes of 38 CU high-risk older adults (mean age: 64 years; p = 0.24) were involved in this study. High-risk participants were defined as having at least one APOE e4 allele and a positive first-degree family history of AD while low-risk participants had neither of the two criteria. All participants had Montreal Cognitive Assessment scores ≥ 26. The mid-peripheral CFZs were computed in MATLAB and compared between the two groups. Results: The periarteriole CFZ of the high-risk group (75.8 ± 9.19 µm) was significantly larger than that of the low-risk group (71.3 ± 7.07 µm), p = 0.005, Cohen’s d = 0.55. The perivenule CFZ of the high-risk group (60.4 ± 8.55 µm) was also significantly larger than that of the low-risk group (57.3 ± 6.40 µm), p = 0.034, Cohen’s d = 0.42. There were no significant differences in foveal avascular zone (FAZ) size, FAZ effective diameter, and vessel density between the two groups, all p > 0.05. Conclusions: Our results show larger mid-peripheral CFZs in CU older adults at high risk for AD, with the potential for the periarteriole CFZ to serve as a novel retinal vascular biomarker for early AD risk detection.Keywords
Funding Information
- National Institute on Aging (R21AG079794, R01AG079241)
- Morton Plant Mease Health Care Foundation
- Warren Alpert Foundation
- National Heart, Lung, and Blood Institute (K23HL150217-04)
This publication has 84 references indexed in Scilit:
- Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problemsAlzheimer's Research & Therapy, 2013
- Assessment of the Virchow-Robin Spaces in Alzheimer Disease, Mild Cognitive Impairment, and Normal Aging, Using High-Field MR ImagingAmerican Journal of Neuroradiology, 2011
- Apolipoprotein E in Alzheimer's disease and other neurological disordersThe Lancet Neurology, 2011
- Statistical power analyses using G*Power 3.1: Tests for correlation and regression analysesBehavior Research Methods, 2009
- Structure versus Function in Glaucoma: An Application of a Linear ModelInvestigative Ophthalmology & Visual Science, 2007
- Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral β amyloid depositsExperimental Neurology, 2003
- The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary Clinical ValidityJournal of Clinical and Experimental Neuropsychology, 1998
- Brain MR: pathologic correlation with gross and histopathology. 1. Lacunar infarction and Virchow-Robin spacesAmerican Journal of Roentgenology, 1988
- Cognitive Function and Prediction of Dementia in Old AgeThe International Journal of Aging and Human Development, 1987
- THE VENOUS DRAINAGE OF THE BRAIN, WITH SPECIAL REFERENCE TO THE GALENIC SYSTEMBrain, 1939